These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22387374)

  • 1. Use of calcium channel blockers and Parkinson's disease.
    Pasternak B; Svanström H; Nielsen NM; Fugger L; Melbye M; Hviid A
    Am J Epidemiol; 2012 Apr; 175(7):627-35. PubMed ID: 22387374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-type calcium channel blockers and Parkinson disease in Denmark.
    Ritz B; Rhodes SL; Qian L; Schernhammer E; Olsen JH; Friis S
    Ann Neurol; 2010 May; 67(5):600-6. PubMed ID: 20437557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Risk of Parkinson's Disease in Users of Calcium Channel Blockers: A Meta-Analysis.
    Gudala K; Kanukula R; Bansal D
    Int J Chronic Dis; 2015; 2015():697404. PubMed ID: 26464872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.
    Wolozin B; Wang SW; Li NC; Lee A; Lee TA; Kazis LE
    BMC Med; 2007 Jul; 5():20. PubMed ID: 17640385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
    Brauer R; Wei L; Ma T; Athauda D; Girges C; Vijiaratnam N; Auld G; Whittlesea C; Wong I; Foltynie T
    Brain; 2020 Oct; 143(10):3067-3076. PubMed ID: 33011770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis.
    Lang Y; Gong D; Fan Y
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):559-66. PubMed ID: 25845582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of dementia in patients with Parkinson's disease, epilepsy, and severe head trauma: a register-based follow-up study.
    Breteler MM; de Groot RR; van Romunde LK; Hofman A
    Am J Epidemiol; 1995 Dec; 142(12):1300-5. PubMed ID: 7503050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study.
    Lee YC; Lin CH; Wu RM; Lin JW; Chang CH; Lai MS
    PLoS One; 2014; 9(6):e98961. PubMed ID: 24910980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.
    Ording AG; Veres K; Horváth-Puhó E; Glymour MM; Rørth M; Henderson VW; Sørensen HT
    J Alzheimers Dis; 2019; 72(4):1269-1277. PubMed ID: 31707368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive agents and risk of Parkinson's disease, essential tremor and dementia: a population-based prospective study (NEDICES).
    Louis ED; Benito-León J; Bermejo-Pareja F;
    Neuroepidemiology; 2009; 33(3):286-92. PubMed ID: 19696520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine calcium channel blockers and the progression of parkinsonism.
    Marras C; Gruneir A; Rochon P; Wang X; Anderson G; Brotchie J; Bell CM; Fox S; Austin PC
    Ann Neurol; 2012 Mar; 71(3):362-9. PubMed ID: 22451203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agricultural work and the risk of Parkinson's disease in Denmark, 1981-1993.
    Tüchsen F; Jensen AA
    Scand J Work Environ Health; 2000 Aug; 26(4):359-62. PubMed ID: 10994803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.
    Lin HF; Liao KF; Chang CM; Lin CL; Lai SW
    Eur J Clin Pharmacol; 2018 Jan; 74(1):99-107. PubMed ID: 28967041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study.
    Chen H; Kwong JC; Copes R; Tu K; Villeneuve PJ; van Donkelaar A; Hystad P; Martin RV; Murray BJ; Jessiman B; Wilton AS; Kopp A; Burnett RT
    Lancet; 2017 Feb; 389(10070):718-726. PubMed ID: 28063597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study.
    Rugbjerg K; Friis S; Jørgensen TL; Ritz B; Korbo L; Olsen JH
    Mov Disord; 2010 Oct; 25(14):2355-60. PubMed ID: 20721917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Associations Between Glucosamine Supplementation and Dementia or Parkinson's Disease: Findings From a Large Prospective Cohort Study.
    Ai B; Chen L; Cai M; Fu J; Li H; Lin H; Zhang Z
    J Gerontol A Biol Sci Med Sci; 2024 Feb; 79(2):. PubMed ID: 37158699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers and beta-blockers in relation to Parkinson's disease.
    Ton TG; Heckbert SR; Longstreth WT; Rossing MA; Kukull WA; Franklin GM; Swanson PD; Smith-Weller T; Checkoway H
    Parkinsonism Relat Disord; 2007 Apr; 13(3):165-9. PubMed ID: 17055323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study.
    Trifirò G; Mokhles MM; Dieleman JP; van Soest EM; Verhamme K; Mazzaglia G; Herings R; de Luise C; Ross D; Brusselle G; Colao A; Haverkamp W; Schade R; van Camp G; Zanettini R; Sturkenboom MC
    Drug Saf; 2012 Feb; 35(2):159-71. PubMed ID: 22204718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.